Naujausios naujienos ir straipsniai apie genetinius tyrimus
May 18, 2026
Researchers at the Medical University of South Carolina have proposed a novel approach that may hold the key to curing type 1 diabetes. This innovative plan aims to harness the body's natural immune response to restore insulin production in individuals with the condition.
May 18, 2026
Researchers at the University of California - Santa Cruz have developed an innovative AI-powered smart bandage that significantly accelerates wound healing. The device has been shown to promote recovery 25% faster than traditional methods.
May 17, 2026
Researchers have identified a novel enzyme in the gut bacteria that could significantly impact our understanding of prebiotics. This discovery may lead to new avenues for the development of probiotics and improved gut health.
May 17, 2026
Researchers at the Scripps Research Institute have made a significant breakthrough in enzyme engineering, potentially leading to new treatments for Parkinson's disease, various cancers, and other protein-related conditions. This innovative approach allows for targeted modifications of enzymes, which could revolutionize the way these diseases are managed.
May 16, 2026
Scripps Research Institute. "Enzyme engineering opens door to novel therapies for Parkinson's, cancers and other hard-to-target protein diseases." ScienceDaily. ScienceDaily, 27 March 2025. <www.sc...
May 16, 2026
Researchers have made significant strides in enzyme engineering, paving the way for innovative treatments of complex diseases such as Parkinson's and certain cancers. This breakthrough holds promise for developing novel therapies that can target hard-to-reach proteins responsible for these conditions.
May 16, 2026
Chiba University. "Targeted alpha therapy: Breakthrough in treating refractory skin cancer." ScienceDaily. ScienceDaily, 12 March 2025. <www.sciencedaily.com/releases/2025/03/250312124420.htm>.
May 16, 2026
Researchers at Chiba University have developed a novel targeted alpha therapy that shows potential in treating skin cancers that are resistant to conventional treatments. This innovative approach uses alpha particles to selectively target and destroy cancer cells, offering new hope for patients with refractory skin cancer.
May 16, 2026
A newly discovered parasite has been found to manipulate its host's pain response, effectively silencing the body's alarm system for pain. This parasite, which infects various species including humans, exploits the host's immune system to evade detection and cause infection.
